Sonic Healthcare Ltd shares down Tuesday, underperforms the Health Care sector
Here is the latest company close update for Sonic Healthcare Ltd, SHL.
Sonic Healthcare
Investors chary of Sonic boom
Sonic Healthcare shares have fallen since it announced its $693m deal to buy LADR Lab Group in Germany this week, despite analysts suggesting that the transaction made sense
Sonic to buy German laboratory business
Sonic Healthcare will buy a German laboratory business for nearly $700m, with the deal including an option over a second business.
Trump a potential positive, Sonic Healthcare says
The mooted ascension of prominent anti-vaxxer Robert F. Kennedy Jr to US Secretary of Health could be a positive for Sonic Healthcare.
ASX 200 at all-time high; CBA hits record
ASX 200 soars to record high on large scale buying before a late selloff. RBA ‘vigilant’ on inflation risks. Goyder to chair Perron Group. TechOne hits record after profit jump on a strong day for tech stocks. CBA, Xero, WiseTech also hit records. Elders dives after capital raise. Santos buoyant on higher returns promise
Sonic lines up for Healius imaging unit
The $12bn Sonic Healthcare has been talking about further acquisitions for years, but one of its next big Australia deals could be just around the corner.
ASX dips as James Hardie, Sonic sink
In a subdued session, Tuesday’s trading gave back a portion of Monday’s rally.
Sonic Healthcare hits profit headwinds
The pathology and radiology provider has cut its annual profit forecast by more than $100m, with inflation and currency headwinds taking their toll.
Helius undervalued, but with work to do
In Part 2 of our look at the ASX’s dominant pathology stocks, Morningstar considers the second-largest operation, Healius and areas it can finetune.
Putting pathology stocks to the test
As the pandemic faded, so did investors’ thirst for now-undervalued ASX pathology stocks, says Morningstar, as it puts Sonic under the microscope.
Sonic Healthcare snaps up Swiss group for $202m
The ASX-listed pathology group has bought Dr Risch as it looks to expand its presence in Switzerland after interim profit dived 47 per cent.
Healthcare giant calls out AI as growth driver
A drop in ‘Covid revenue’ punched a hole in Sonic Healthcare’s results but it called out AI as part of a $350m growth strategy.
ASX snaps loss streak; Collins Foods soars 18pc
Collins Foods jumps on eight-month high after earnings beat. Iron ore in biggest jump since May. Bega to sell $115m Port Melbourne site. Medibank falls on APRA’s $250m hit.
ASX health small caps dishing out dividends
Small cap health stocks commonly don’t pay dividends. But these ASX players have been handing out – not burning through – cash.
Healthy improvement for this ASX duo
Health stock CleanSpace has made impressive gains after making headway in the US. Meanwhile, Sonic jumped despite falling revenue.
Sonic’s post-Covid growth sends shares soaring
Despite a massive decline in PCR tests to detect Covid-19, the group’s net profit is still well up on pre-pandemic levels, triggering a share rally.
ASX gains 0.8pc on Orora, Sonic; AMP dives 13pc
Shares rally the most in a month after a rise in the jobless rate. Orora and Sonic Healthcare rocket on earnings beat. AMP dives on profit miss. ANZ says higher rates for longer.
Sonic, Proteomics edge closer to major medical breakthrough
Pathology giant Sonic Healthcare and life sciences company Proteomics partner to develop a world-first for people with kidney disease.
Australians ditching Covid-19 PCR tests cause Sonic dive
After delivering pathology companies a bonanza, government-funded pathology testing to diagnose Covid-19 has fallen dramatically, Sonic Healthcare’s latest trading update reveals.
Covid-19 delivers Sonic Healthcare a $2.4bn bonanza
The pandemic and taxpayer-funded Covid-19 tests has propelled ASX-listed pathology group Sonic Healthcare to deliver record revenue of $9.34bn.
Vaping surge a ‘health crisis’ in the making
The number of Australians aged 14 and over using vapes has more than doubled, according to a report that found e-cigarettes could cause seizures and lung injuries.
Revealed: the post pandemic windfall set to hit pathology giants
Pathology companies Sonic Healthcare, Healius, Australian Clinical Labs and Integral Diagnostics score big from Covid testing.
Revealed: The firms set to earn billions from Covid tests
Two major pathology providers have already experienced multibillion-dollar revenue uplifts amid a testing boom, as analysts predict even more to come.
ASX closes up on banks, miners and health
Australian markets have closed 0.2 per cent higher amid stronger global shares with Crown Resorts gaining on a new offer.
Icon calls on Sonic chair ahead of float
Australia’s largest cancer care provider, Icon Group, could be about to make some changes to its board ahead of a potential sale or float.
‘Fear of infection’ hits pathology profits
Sonic Healthcare says full-year profits fell because patients stayed away due to COVID restrictions and infection worries.
Sonic buys German lab group
Sonic expects the chain of German pathology labs to boost earnings in the first year.
Sonic profit soars 30pc
Sonic Healthcare expects earnings growth to pick up over the coming year, as the stoush over bulk billing subsides.
Original URL: https://www.theaustralian.com.au/topics/sonic-healthcare